Abstract #1256

Simultaneous PET and MRSI of Prostate Cancer

Kirsten Margrete Selnæs^1,2, Morteza Esmaeili¹, Nassim Tayari³, Tom Scheenen³, Mattijs Elschot¹, Arend Heerschap³, and Tone Frost Bathen¹

¹Department of Circulation and Medical Imaing, NTNU - Norwegian University of Science and Technology, Trondheim, Norway, ²St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway, ³Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, Netherlands

Both positron emission tomography (PET) and magnetic resonance spectroscopic imaging (MRSI) can give important information about cancer metabolism. With an integrated PET/MR scanner, MRSI and PET images can be acquired simultaneously. The aim of this study was to examine possible correlations between ¹⁸F-Fluciclovine PET and MRSI measurements and evaluate their diagnostic performance in prostate cancer. The results showed a significant moderate correlation between both SUV_mean and SUV_max and the CCS/C ratio. A combination of the imaging outcomes derived from the integrated PET-MRSI modalities improved the localization accuracy of prostate cancer lesions.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.